AWH (Aspira Women's Health) צמיחת רווחים בשנה הנוכחית

Aspira Women's Health is expanding oncology diagnostics through partnerships with medical centers. The GURU.Markets terminal provides a chart of the relative annual growth of net income per share with a metric value of 50.90. Aspira Women's Health is implementing bioanalytical IT platforms, minimizing risks via its laboratory network. Competition with large networks is forcing the business to expand its proprietary test portfolio to maintain market share.
פילוחים אנליטיים ודוחות נתונים של חברת Aspira Women's Health Inc. (AWH)

Fundamental asset selection requires separating short-term market fluctuations from real operational business efficiency. This indicator measures the annual percentage change in earnings per share, smoothing out one-time noise to assess the issuer's long-term sustainability. In the context of an independent sovereign cycle, the 50.90 value for Aspira Women's Health (AWH) confirms the defensive qualities of the investment, which is clearly reflected in the YoY earnings per share price action.